Alexandra Pearce
Keine laufenden Positionen mehr
Profil
Alexandra Pearce worked as an Executive Director of Regulatory Affairs & Safety at Amgen, Inc. from 2006 to 2010.
Prior to that, she was the Director of Worldwide Regulatory Strategy at Pfizer Inc. from 1995 to 2006.
From 2010 to 2016, she worked as the Executive Vice President & Head of Regulatory Affairs at Glenmark Pharmaceuticals Europe Ltd.
Pearce then worked as the Vice President & Head of Regulatory Affairs at Abivax SA. From 2016 to 2018, she was the Chief Operations Officer & Head of Regulatory Affairs at Viramal Ltd.
Pearce earned a doctorate degree from The Open University in 1993.
Ehemalige bekannte Positionen von Alexandra Pearce
| Unternehmen | Position | Ende |
|---|---|---|
Viramal Ltd.
 Viramal Ltd. BiotechnologyHealth Technology Viramal Ltd. operates as a biotechnology company and develops drugs for male and female sexual and hormone problems. The company was founded by Oliver Bates and Finn Larsen in 2013 and is headquartered in London, the United Kingdom. | Chief Operating Officer | 01.04.2018 |
Glenmark Pharmaceuticals Europe Ltd.
 Glenmark Pharmaceuticals Europe Ltd. Pharmaceuticals: MajorHealth Technology Part of Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals Europe Ltd. is a British pharmaceutical company that is discovering advanced therapies for dermatology, oncology, and inflammation. Founded in 2004, the private company is based in Harrow, UK. Glenmark's R&D is committed to identifying products that fulfill unique and unmet medical needs. The company began its operations in the market of exporting branded formulations to countries and provides financial results, announcements, and reports for investors and shareholders. | General Counsel | 01.07.2016 |
| AMGEN INC. | General Counsel | 01.06.2010 |
| PFIZER, INC. | Corporate Officer/Principal | 01.05.2006 |
| ABIVAX | General Counsel | - |
Ausbildung von Alexandra Pearce
| The Open University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| ABIVAX | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Glenmark Pharmaceuticals Europe Ltd.
Glenmark Pharmaceuticals Europe Ltd. Pharmaceuticals: MajorHealth Technology Part of Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals Europe Ltd. is a British pharmaceutical company that is discovering advanced therapies for dermatology, oncology, and inflammation. Founded in 2004, the private company is based in Harrow, UK. Glenmark's R&D is committed to identifying products that fulfill unique and unmet medical needs. The company began its operations in the market of exporting branded formulations to countries and provides financial results, announcements, and reports for investors and shareholders. | Health Technology |
Viramal Ltd.
Viramal Ltd. BiotechnologyHealth Technology Viramal Ltd. operates as a biotechnology company and develops drugs for male and female sexual and hormone problems. The company was founded by Oliver Bates and Finn Larsen in 2013 and is headquartered in London, the United Kingdom. | Health Technology |
